DNA Factories
2007 04 12

By Emily Singer | technologyreview.com

Picked up from: radiOrbit Forum

Cheaply churning out made-to-order DNA could revolutionize molecular biology.

Installing one of those prefab, snap-together wood-flooring kits is a lot easier than shaping and sanding rough planks. Adapting a similar construction strategy, a biotech startup called Codon Devices, based in Cambridge, MA, aims to streamline genetic engineering. It makes made-to-order DNA strands, freeing scientists from the finicky work it takes to put together a complicated piece of DNA the old-fashioned way.

That capability could soon change the face of molecular biology. As it becomes cheaper and cheaper to create large chunks of genetic material from scratch, scientists will be able to make ever more complex biological creations. "In the next few years, we'll probably see people engineering cells to do drug delivery or creating cellular sensors," says George Church, a professor of genetics at Harvard and one of Codon's founders. "Maybe even cells that make inorganic objects of interest, like nanostructures."

Codon was founded in 2005 just as the fledgling field of synthetic biology--the quest to design and build new life forms that can perform useful functions--was beginning to take off. The ability to make complex genetic constructs is a cornerstone of the field, allowing scientists to use chunks of DNA to design novel biological parts, which can then be inserted into bacteria or other cells. (See "Synthetic Biology on Display.")

While DNA synthesis is still too expensive to replace more-traditional molecular-biology methods on a broad scale, experts say that the DNA-synthesis market is about to boom, much as the DNA-sequencing market has in the past few years. As sequencing costs plummeted, the number of sequencing projects surged, with record numbers of genomes--even entire microbial communities--being sequenced. "As large companies begin to adopt this technology, the volumes of DNA synthesis will explode," says John Danner, president and chief executive officer of Codon. "When that happens, thousands of scientists will think about this when they go to sleep at night, and that will change how biotech is done."

Last summer, the company created what it believes was the biggest piece of man-made DNA, a 35,000 base-pair strand incorporating several genes needed to synthesize a pharmaceutical compound. The DNA was made for Microbia, another Cambridge-based biotech, which is creating microbes to manufacture specialty chemicals. But the potential applications are broad, spanning pharmaceuticals, energy, and agriculture.

Synthetic biologists are excited about the prospects, but they're still waiting for a decrease in price to the point that they can afford to do the experiments they want to do. "Cost is the critical component to making this technology work," says Chris Voigt, a synthetic biologist at the University of San Francisco. "Right now, we can design one construct that costs a fortune to make. But we want to be able to order different components put together in different ways so we can study the critical factor in putting them together."

Codon is confident that that day will soon come. It plans to use its enhanced synthesis capacity to find better enzymes for industrial processes. Since nature hasn't always come up with the most effective proteins, scientists often design a more effective enzyme by tweaking the DNA code used to make it. But it's difficult to predict in advance which tweaks will produce the best enzymes. Codon is now using its synthesis technology to carry out that process en masse--it makes millions of copies of the same genetic construct with slight variations--and then tests them to figure out which does its job best.

For example, scientists are now hot on the trail of the ideal cellulase--an enzyme that can break down cellulose in plants. More-efficient cellulases are important for producing cellulosic ethanol, which is ethanol derived from waste biomass rather than from corn starch or sugarcane, and therefore more cost-effective. "We can take the sequence for the cellulose enzyme in, say, a termite's gut, use a computer program to figure out different ways to optimize the sequence, churn out a million different versions, and then test them to find the top ten forms," says Brian Baynes, chief scientific officer and cofounder of Codon.

The same process could be used to develop protein-based drugs that can better bind to their targets or more efficiently break down a toxin in the blood. "Knowing that they can test variations of things will get molecular biologists working more like engineers," says Danner.

The company is planning to open an expanded production facility, which will operate much like any other mass-production facility, except its product will be DNA. Codon intends to build a facility, slated to open this summer, that's much larger than current needs warrant to prepare for the DNA-synthesis boom.

Article from: http://www.technologyreview.com/Biotech/18503/page2/



Related Articles
DeoxyriboNucleic Acid (DNA)
Team develops DNA switch to interface living organisms with computers
Deep DNA memory theories: Can we remember our ancestors’ lives?
Scientist Calls For World DNA Database
DNA evidence for Atlantis
The discovery of DNA variability, holographic blueprints and the symphony of life
Finding the Holy Grail


Latest News from our Front Page

Hungary’s Orban Bashes Liberal Immigration Policy
2014 08 29
Hungary’s Prime Minister Viktor Orban on Monday lashed out against immigration, setting one of the main policy objectives of his next term in power after winning parliamentary elections in April. “The goal is to cease immigration whatsoever,” said Hungary’s prime minister. “I think the current liberal immigration policy, which is considered obvious and morally based, is hypocrite,” Mr. Orban said. At a ...
China’s “Duplitecture” Cities Mimic the World’s Greatest Architectural Hits
2014 08 29
The best knockoffs in the world are in China. There are plenty of fake designer handbags and Rolexes, but China’s knockoffs go way beyond fashion. There are knockoff Apple stores that look so much like the real thing that some employees believe they are working in real Apple stores. And then there are entire knockoff cities. There are Venices with ...
Kiev loses control of Novoazovsk, rebel troops advance in southeast Ukraine
2014 08 29
Kiev’s troops had to leave the eastern Ukrainian city of Novoazovsk to save their lives, said the country’s Security and Defense Council. The authorities admitted that self-defense forces are advancing and leading a counteroffensive in the southeast. Along with Novoazovsk, Kiev troops have lost control over the villages of Amvrosiivka and Starobeshevo in the Donetsk Region of Eastern Ukraine. According to Ukraine’s ...
Mohammed is most popular name in Oslo
2014 08 29
For the first time in the capital city’s history, Mohammed is the most common name for boys and men, said a study on Thursday. Statistics Norway (Statistisk Sentralbyrå - SSB) has counted the population of Oslo and found that Mohammed is the most common male name in Oslo for the first time ever. Jørgen Ouren of SSB said to NRK: “It is ...
Beaten to Death at McDonald’s
2014 08 29
To the four clean-cut college freshman out on a double date, it had seemed like a typical McDonald’s: spanking clean, well-lighted, and safe. It was in a good neighborhood too, right next to Texas A&M University in College Station -- a campus known for its friendly atmosphere and official down-home greeting: “howdy.” Shortly after 2 A.M. that Sunday, they pulled into ...
More News »